|
|
||||||||



*
Institut National de la Santé et de la Recherche Médicale Unité 399, Marseille, France;
Institut de Médecine Tropicale du Service de Santé des Armées, Marseille, France;
Department of Pathology, University of Geneva, Geneva, Switzerland;
§
Institute for Animal Health, Pirbright, United Kingdom; and
¶
Medical Research Council Laboratory of Molecular Biology, Cambridge, United Kingdom
The Cd22 gene encodes a B cell-specific adhesion
molecule that modulates B cell Ag receptor-mediated signal
transduction, and is allelic to a lupus-susceptibility locus in New
Zealand White (NZW) mice. In this study, we show that, in addition to
the wild-type transcripts, NZW
(Cd22a) mice synthesize
aberrant CD22 mRNAs that contain
20120 nucleotide insertions
upstream of the coding region between exons 2 and 3, and/or
100190
nucleotide deletions of exon 4. Sequence analysis revealed that these
aberrant mRNA species arose by alternative splicing due to the presence
in the NZW strain of a 794-bp sequence insertion in the second intron,
containing a cluster of short interspersed nucleotide elements. Both
the presence of sequence insertion and aberrantly spliced mRNAs were
specific to mice bearing the
Cd22a and
Cd22c alleles.
Up-regulation of CD22 expression after LPS activation appeared impaired
in Cd22a spleen cells (twice
lower than in Cd22b B cells).
Furthermore, we show that partial CD22 deficiency, i.e., heterozygous
level of CD22 expression, markedly promotes the production of IgG
anti-DNA autoantibodies in C57BL/6
(Cd22b) mice bearing the Y
chromosome-linked autoimmune acceleration gene, Yaa.
Taken together, these results suggest that a lower up-regulation of
CD22 on activated B cells (resulting from Cd22 gene
anomaly in Cd22a mice or from
CD22 heterozygosity in mutants obtained by gene targeting) is
implicated in autoantibody production, providing support for
Cd22a as a possible candidate
allele contributing to lupus susceptibility.
This article has been cited by other articles:
![]() |
L. C. Watson, C. S. Moffatt-Blue, R. Z. McDonald, E. Kompfner, D. Ait-Azzouzene, D. Nemazee, A. N. Theofilopoulos, D. H. Kono, and A. J. Feeney Paucity of V-D-D-J Rearrangements and VH Replacement Events in Lupus Prone and Nonautoimmune TdT-/- and TdT+/+ Mice J. Immunol., July 15, 2006; 177(2): 1120 - 1128. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pisitkun, J. A. Deane, M. J. Difilippantonio, T. Tarasenko, A. B. Satterthwaite, and S. Bolland Autoreactive B Cell Responses to RNA-Related Antigens Due to TLR7 Gene Duplication Science, June 16, 2006; 312(5780): 1669 - 1672. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Varki and T. Angata Siglecs--the major subfamily of I-type lectins Glycobiology, January 1, 2006; 16(1): 1R - 27R. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Nitschke, F. Lajaunias, T. Moll, L. Ho, E. Martinez-Soria, S. Kikuchi, M.-L. Santiago-Raber, C. Dix, R. M. E. Parkhouse, and S. Izui Expression of aberrant forms of CD22 on B lymphocytes in Cd22a lupus-prone mice affects ligand binding Int. Immunol., January 1, 2006; 18(1): 59 - 68. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kikuchi, H. Amano, E. Amano, L. Fossati-Jimack, M.-L. Santiago-Raber, T. Moll, A. Ida, B. L. Kotzin, and S. Izui Identification of 2 major loci linked to autoimmune hemolytic anemia in NZB mice Blood, August 15, 2005; 106(4): 1323 - 1329. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Moll, L. Nitschke, M. Carroll, J. V. Ravetch, and S. Izui A Critical Role for Fc{gamma}RIIB in the Induction of Rheumatoid Factors J. Immunol., October 1, 2004; 173(7): 4724 - 4728. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Asano, M. Fujimoto, N. Yazawa, S. Shirasawa, M. Hasegawa, H. Okochi, K. Tamaki, T. F. Tedder, and S. Sato B Lymphocyte Signaling Established by the CD19/CD22 Loop Regulates Autoimmunity in the Tight-Skin Mouse Am. J. Pathol., August 1, 2004; 165(2): 641 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Lajaunias, L. Nitschke, T. Moll, E. Martinez-Soria, I. Semac, Y. Chicheportiche, R. M. E. Parkhouse, and S. Izui Differentially Regulated Expression and Function of CD22 in Activated B-1 and B-2 Lymphocytes J. Immunol., June 15, 2002; 168(12): 6078 - 6083. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. HASLER and M. ZOUALI B cell receptor signaling and autoimmunity FASEB J, October 1, 2001; 15(12): 2085 - 2098. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Kono, M. S. Park, A. Szydlik, K. M. Haraldsson, J. D. Kuan, D. L. Pearson, P. Hultman, and K. M. Pollard Resistance to Xenobiotic-Induced Autoimmunity Maps to Chromosome 1 J. Immunol., August 15, 2001; 167(4): 2396 - 2403. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. U. Rudge, A. J. Cutler, N. R. Pritchard, and K. G.C. Smith Interleukin 4 Reduces Expression of Inhibitory Receptors on B Cells and Abolishes CD22 and Fc{gamma}RII-mediated B Cell Suppression J. Exp. Med., April 15, 2002; 195(8): 1079 - 1085. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bolland, Y.-S. Yim, K. Tus, E. K. Wakeland, and J. V. Ravetch Genetic Modifiers of Systemic Lupus Erythematosus in Fc{gamma}RIIB-/- Mice J. Exp. Med., May 6, 2002; 195(9): 1167 - 1174. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |